Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
05:47:29 EDT Fri 19 Apr 2024
Enter Symbol
or Name
USA
CA



Q:ERNA - ETERNA THERAPEUTICS INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ERNA - Q5.02.07·2.305.02.154.89432.06  2.16  2.063.45  0.8401Apr 18Feb 2015 min RT 2¢

Recent Trades - Last 10 of 43
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-02-20 08:30U:ERNANews ReleaseEterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors
2024-01-03 16:15U:ERNANews ReleaseEterna Therapeutics Grants New President and CEO Sanjeev Luther Inducement Award Under Nasdaq Listing Rule 5635 (c)(4)
2023-12-20 16:16U:ERNANews ReleaseEterna Therapeutics Names Sanjeev Luther as President and Chief Executive Officer
2023-12-14 18:56U:ERNANews ReleaseEterna Therapeutics Announces $9.2 Million Convertible Debt and Warrant Financing
2023-11-01 08:30U:ERNANews ReleaseEterna Therapeutics Appoints James Bristol, Ph.D., Pharmaceutical Research and Drug Discovery Veteran, to Board of Directors
2023-09-06 08:00U:ERNANews ReleaseEterna Therapeutics Announces Initiation of Development Activities for Hypoimmune Pluripotent Cell Line for Neurology Indications Under Partnership With Lineage Cell Therapeutics
2023-09-05 08:31U:ERNANews ReleaseEterna Therapeutics Appoints Biopharma Industry Veteran Dorothy Clarke to Board of Directors
2023-07-18 08:00U:ERNANews ReleaseEterna Therapeutics Announces Completion of $8.7 Million of Convertible Debt Financing
2023-07-11 08:30U:ERNANews ReleaseEterna Therapeutics Appoints Biotech Industry Veterans Brant Binder and Richard Wagner, Ph.D. to Board of Directors
2023-05-24 08:30U:ERNANews ReleaseEterna Therapeutics Appoints Megan Yung as Chief Strategy Officer, General Counsel
2023-05-17 08:31U:ERNANews ReleaseEterna Therapeutics and Factor Bioscience Announce New Data on Multi-Cell-Type Therapeutic Approach at American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting
2023-05-04 08:30U:ERNANews ReleaseEterna Therapeutics to Deliver Eight Presentations at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting
2023-05-02 07:30U:ERNANews ReleaseEterna Therapeutics Acquires Allogeneic Immuno-Oncology Platform from Exacis Biotherapeutics